The global cancer divide: Relationships between national healthcare resources and cancer outcomes in high-income vs. middle- and low-income countries
Open Access
- 1 January 2013
- journal article
- Published by Springer Nature in Journal of Epidemiology and Global Health
- Vol. 4 (2) , 115-24
Abstract
Cancer continues to rise as a contributor to premature death in the developing world. Despite this, little is known about whether cancer outcomes are related to a country's income level, and what aspects of national healthcare systems are associated with improved cancer outcomes. The most recent estimates of cancer incidence and mortality were used to calculate mortality-to-incidence ratio (MIR) for the 85 countries with reliable data. Countries were categorized according to high-income (Gross Domestic Product (GDP)>$15,000) or middle/low-income (GDP<$15,000), and a multivariate linear regression model was used to determine the association between healthcare system indicators and cancer MIR. Indicators study included per capita GDP, overall total healthcare expenditure (THE), THE as a proportion of GDP, total external beam radiotherapy devices (TEBD) per capita, physician density, and the year 2000 WHO healthcare system rankings. Cancer MIR in high-income countries (0.47) was significantly lower than that of middle/low-income countries (0.64), with a p<0.001. In high-income countries, GDP, health expenditure and TEBD showed significant inverse correlations with overall cancer MIR. A $3040 increase in GDP (p=0.004), a $379 increase in THE (p<0.001), or an increase of 0.59 TEBD per 100,000 population (p=0.027) were all associated with a 0.01 decrease in cancer MIR. In middle/low-income countries, only WHO scores correlated with decreased cancer MIR (p=0.022); 12 specific cancer types also showed similar significant correlations (p<0.05) as overall cancer MIR. The analysis of this study suggested that cancer MIR is greater in middle/low-income countries. Furthermore, the WHO healthcare score was associated with improved cancer outcomes in middle/low-income countries while absolute levels of financial resources and infrastructure played a more important role in high-income countries.Keywords
This publication has 15 references indexed in Scilit:
- Projections of the Cost of Cancer Care in the United States: 2010-2020JNCI: Journal of the National Cancer Institute, 2011
- The validity of the mortality to incidence ratio as a proxy for site-specific cancer survivalEuropean Journal of Public Health, 2010
- Ranking 37th — Measuring the Performance of the U.S. Health Care SystemNew England Journal of Medicine, 2010
- Mapping cancer mortality‐to‐incidence ratios to illustrate racial and sex disparities in a high‐risk populationCancer, 2009
- Part I: Cancer in Indigenous Africans—burden, distribution, and trendsThe Lancet Oncology, 2008
- Role of radiotherapy in cancer control in low-income and middle-income countriesThe Lancet Oncology, 2006
- Socio-economic factors and health care system characteristics related to cancer survival in the elderlyCritical Reviews in Oncology/Hematology, 2005
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Millions in developing world deprived of radiotherapyThe Lancet Oncology, 2003
- Cancer in the developing world: a call to actionBMJ, 1999